Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study

Vitamin K (vitamin K1 or phylloquinone and vitamin K2, a series of menaquinones [MKs]) is involved in the production of bone and matrix amino acid γ‐carboxy‐glutamic acid (Gla) proteins, regulating bone and vascular calcification. Low vitamin K concentrations are associated with increased risks of fractures and vascular calcification, and frequent complications in hemodialysis patients. We carried out an observational study to establish the prevalence of vitamin K deficiency and to assess the relationship between vitamin K status, vertebral fractures, vascular calcification, and survival in 387 patients on hemodialysis for ≥1 year. We determined plasma levels of vitamin K compound, bone‐Gla‐protein, matrix‐Gla‐protein, and routine biochemistry. Vertebral fractures (reduction in vertebral body height by ≥20%) and aortic and iliac calcifications were also investigated in a spine (D5–L4) radiograph. Three‐year patient survival was analyzed. Important proportions of patients had deficiency of MK7 (35.4%), vitamin K1 (23.5%), and MK4 (14.5%). A total of 55.3% of patients had vertebral fractures, 80.6% had abdominal aorta calcification, and 56.1% had iliac calcification. Vitamin K1 deficiency was the strongest predictor of vertebral fractures (odds ratio [OR], 2.94; 95% confidence interval [CI], 1.38–6.26). MK4 deficiency was a predictor of aortic calcification (OR, 2.82; 95% CI, 1.14–7.01), whereas MK5 deficiency actually protected against it (OR, 0.38; 95% CI, 0.15–0.95). MK7 deficiency was a predictor of iliac calcification (OR, 1.64; 95% CI, 1.03–2.60). The presence of vertebral fractures was also a predictor of vascular calcifications (OR, 1.76; 95% CI, 1.00–3.08). Increased alkaline phosphatase and C reactive protein (CRP), age, and cerebrovascular events were predictors of mortality. Our study suggests that the vitamin K system may be important for preserving bone mass and avoiding vascular calcification in hemodialysis patients, pointing out a possible role of vitamin K in bone and vascular health. Based on our results, we suggest that the general population should also be studied for vitamin K deficiency as a possible cause of both vertebral fractures and vascular calcification. © 2012 American Society for Bone and Mineral Research.

[1]  Y. Fujita,et al.  Association between vitamin K intake from fermented soybeans, natto, and bone mineral density in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) study , 2012, Osteoporosis International.

[2]  G. Eide,et al.  Intake of vitamin K1 and K2 and risk of hip fractures: The Hordaland Health Study. , 2011, Bone.

[3]  F. Dekker,et al.  Bone alkaline phosphatase and mortality in dialysis patients. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[4]  R. Estruch,et al.  Dietary vitamin K intake is associated with bone quantitative ultrasound measurements but not with bone peripheral biochemical markers in elderly men and women. , 2011, Bone.

[5]  A. Avenell,et al.  Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis , 2011, BMJ : British Medical Journal.

[6]  S Giannini,et al.  Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: an important but poorly studied relationship. , 2011, Journal of endocrinological investigation.

[7]  N. Tsugawa,et al.  High prevalence of hypovitaminosis D and K in patients with hip fracture. , 2011, Asia Pacific journal of clinical nutrition.

[8]  L. Schurgers,et al.  Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. , 2011, Journal of the American Society of Nephrology : JASN.

[9]  D. Brancaccio,et al.  The mechanisms of hyperphosphatemia-induced vascular calcification , 2008, The International journal of artificial organs.

[10]  George Tomlinson,et al.  Vitamin K Supplementation in Postmenopausal Women with Osteopenia (ECKO Trial): A Randomized Controlled Trial , 2008, PLoS medicine.

[11]  M. Shearer,et al.  Metabolism and cell biology of vitamin K , 2008, Thrombosis and Haemostasis.

[12]  L. Schurgers,et al.  Matrix Gla-protein: The calcification inhibitor in need of vitamin K , 2008, Thrombosis and Haemostasis.

[13]  J. Cannata-Andía,et al.  Vascular calcifications, vertebral fractures and mortality in haemodialysis patients , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  L. Schurgers,et al.  The Circulating Inactive Form of Matrix Gla Protein (ucMGP) as a Biomarker for Cardiovascular Calcification , 2008, Journal of Vascular Research.

[15]  T. M. Link,et al.  Vertebral morphometry: current methods and recent advances , 2008, European Radiology.

[16]  J. Cannata-Andía,et al.  Progression of vascular calcifications is associated with greater bone loss and increased bone fractures , 2008, Osteoporosis International.

[17]  N. Binkley,et al.  Vitamin K Deficiency From Long‐Term Warfarin Anticoagulation Does Not Alter Skeletal Status in Male Rhesus Monkeys , 2007, Journal of Bone and Mineral Research.

[18]  Raymond Vanholder,et al.  EBPG guideline on nutrition. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  Lisa M. Miller,et al.  Subclinical vitamin K deficiency in hemodialysis patients. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  L. Arab,et al.  Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. , 2006, Kidney international.

[21]  R. Terkeltaub,et al.  Low vitamin K status is associated with osteoarthritis in the hand and knee. , 2006, Arthritis and rheumatism.

[22]  A. Hofman,et al.  Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. , 2004, The Journal of nutrition.

[23]  D. Kiel,et al.  Vitamin K intake and bone mineral density in women and men. , 2003, The American journal of clinical nutrition.

[24]  Craig S. Wong,et al.  Risk factors for hip fracture among patients with end-stage renal disease. , 2000, Kidney international.

[25]  Craig S. Wong,et al.  Increased risk of hip fracture among patients with end-stage renal disease. , 2000, Kidney international.

[26]  D. Kiel,et al.  Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. , 2000, The American journal of clinical nutrition.

[27]  R. Behringer,et al.  Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein , 1997, Nature.

[28]  Allan Bradley,et al.  Increased bone formation in osteocalcin-deficient mice , 1996, Nature.

[29]  S. Cummings,et al.  Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis , 1996 .

[30]  J. Taylor,et al.  Normal range estimation for repeated immunologic measures , 1996, Clinical and diagnostic laboratory immunology.

[31]  D. E. Grobbee,et al.  J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis , 1994, The Lancet.

[32]  P. Garry,et al.  Phylloquinone in plasma from elderly and young adults: factors influencing its concentration. , 1989, The American journal of clinical nutrition.

[33]  L. Schurgers,et al.  Effects of the blood coagulation vitamin K as an inhibitor of arterial calcification. , 2008, Thrombosis research.

[34]  Chittaranjan Andrade,et al.  Confounding , 2007, Indian journal of psychiatry.

[35]  N. Chen,et al.  Vascular calcification in chronic kidney disease. , 2004, Seminars in nephrology.